Title

Nivolumab (NIVO) chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 5-year (y) follow-up results from CheckMate 649.

Authors

Janjigian, Yelena Y.; Moehler, Markus H.; Ajani, Jaffer A.; Shen, Lin; Garrido, Marcelo; Gallardo, Carlos; Wyrwicz, Lucjan; Yamaguchi, Kensei; Cleary, James M.; Elimova, Elena; Bruges, Ricardo Elias; Karamouzis, Michalis; Skoczylas, Tomasz; Bragagnoli, Arinilda; Liu, Tianshu; Tehfe, Mustapha; McCraith, Stephen; Hu, Nan; Zhang, Jennifer; Shitara, Kohei

Publication

Journal of Clinical Oncology, 2025, Vol 43, p398

ISSN

0732-183X

Publication type

Academic Journal

DOI

10.1200/JCO.2025.43.4_suppl.398